Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Occult Hepatitis B Infection in Cancer Patients”

2 trials

Showing 2 of 2 results

Large-scale testing (Phase 3)UnknownNCT02991638
What this trial is testing

Efficacy and Safety of Ibrutinib in Patients With CLL and Other Indolent B-cell Lymphomas Who Are Chronic Hepatitis B Virus Carriers or Occult Hepatitis B Virus Carriers

Who this might be right for
Chronic Lymphocytic LeukemiaIndolent B-cell LymphomasChronic Hepatitis B+4 more
The University of Hong Kong 62
Not applicableActive Not RecruitingNCT06347588
What this trial is testing

Risk of Reactivation of Occult Hepatitis B in Cancer Patients During Immunotherapy.

Who this might be right for
Occult Hepatitis B Infection in Cancer Patients
Fondazione IRCCS Policlinico San Matteo di Pavia 60

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation